Second-Line And Maintenance Therapy in Metastatic Pancreatic Cancer
Thomas A. Abrams, MD, provides an overview of the CONKO-003, PANCREOX, NAPOLI-1, and POLO trials for second-line and maintenance treatment of metastatic pancreatic cancer, respectively.
Related Videos
Related Content
